Lv511
930 积分 2022-06-29 加入
Cost-Effectiveness of Semaglutide in Patients With Obesity and Cardiovascular Disease
12小时前
已完结
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
20小时前
待确认
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis
5天前
已完结
rcssci: An R Package for Visualization of Restricted Cubic Spline
14天前
已完结
Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations
15天前
已完结
Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study
15天前
已完结
Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards
23天前
已完结
Interpreting the impact of apalutamide on overall survival among patients with non-metastatic castration-resistant prostate cancer
23天前
已关闭
Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes
23天前
已完结
Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio
23天前
已完结
皖公网安备34019202002308
